The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
We invest in and build companies with pioneering pharmaceutical and biotech projects or adjacent capabilities.
Investment firmStockholm, Swedenflerie.comSince 2026-09-29
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
AnaCardio A clinical-stage biopharmaceutical company developing novel therapies for heart failure | Series B Verified against 1 of 17 sources | $71.0M | 2026-09-29 | [ PART ] |